Target intelligence / Profile preview

Vascular endothelial growth factor receptor 1, 2, 3 (VEGFRs)

Target
VEGFRs
Molecular classification
Receptor, Receptor tyrosine kinase
01

Overview

Vascular endothelial growth factor receptor 1, 2, and 3 refer to a family of three distinct, but structurally and functionally related, receptor tyrosine kinases. While each receptor has unique primary roles (e.g., VEGFR1 in decoy signaling and monocyte chemotaxis, VEGFR2 in angiogenesis, VEGFR3 in lymphangiogenesis), they collectively mediate various aspects of vascular and lymphatic development, maintenance, and pathological processes. This entry is considered 'incorrect' for structured extraction as these are individually targetable proteins that should be treated separately for accurate annotation and data integrity.

Other names
VEGF receptor familyVEGF receptors
02

Mechanism of action

Drugs targeting these receptors primarily act through inhibition of VEGF-ligand binding, thereby preventing receptor activation, or by directly inhibiting the receptor's intrinsic tyrosine kinase activity, and in some cases, by sequestering ligands.

03

Biological functions

AngiogenesisLymphangiogenesisVascular development and integrityCell proliferation and migrationSignal transductionMonocyte/macrophage chemotaxisLigand sequestration (decoy function)
04

Disease associations

CancerInflammationCardiovascular diseaseRetinopathyLymphatic disordersLymphedema
05

Safety considerations

Impaired wound healingHypertensionThromboembolic eventsProteinuriaHemorrhageGastrointestinal perforationCardiovascular adverse eventsLymphatic dysfunctionCompromised immune surveillance
06

Interacting drugs

Bevacizumab

8 more in the full profile.

07

Biomarkers

Soluble receptor forms (sVEGFR1, sVEGFR2, sVEGFR3)Phosphorylated receptor forms (pVEGFR2)Receptor expression (e.g., VEGFR3 in lymphatic endothelium)

Beyond the preview

Go deeper on Vascular endothelial growth factor receptor 1, 2, 3 (VEGFRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular endothelial growth factor receptor 1, 2, 3 (VEGFRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call